Loading...
XSHE
300633
Market cap1.64bUSD
Dec 05, Last price  
26.94CNY
1D
0.79%
1Q
-16.67%
IPO
225.36%
Name

SonoScape Medical Corp

Chart & Performance

D1W1MN
XSHE:300633 chart
P/E
81.31
P/S
5.75
EPS
0.33
Div Yield, %
1.19%
Shrs. gr., 5y
1.45%
Rev. gr., 5y
9.94%
Revenues
2.01b
-5.02%
484,247,538592,242,346639,724,282685,826,920719,356,862989,069,6631,226,848,9651,253,853,5751,163,081,8691,444,597,6281,762,648,9812,120,251,6042,013,856,558
Net income
142m
-68.67%
129,941,41470,649,079131,752,489105,871,308130,427,136190,023,097252,623,779101,536,9450247,244,612369,807,923454,437,474142,397,376
CFO
307m
-37.91%
15,488,30089,944,601113,548,68156,285,693137,377,685136,205,027233,647,896190,393,067271,131,439302,989,915473,255,552493,877,095306,658,255
Dividend
May 29, 20240.32 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.
IPO date
Apr 06, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT